Page last updated: 2024-08-21

diphenylamine and Lymphoma

diphenylamine has been researched along with Lymphoma in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
De Vos, J; Klein, B; Moreaux, J; Veyrune, JL	1
Clemetson, KJ	1

Other Studies

2 other study(ies) available for diphenylamine and Lymphoma

Article	Year
APRIL is overexpressed in cancer: link with tumor progression. BMC cancer, 2009, Mar-16, Volume: 9 Topics: B-Cell Activating Factor; B-Cell Activation Factor Receptor; B-Lymphocytes; Biomarkers, Tumor; Carcinoma; Cell Proliferation; Cell Survival; Diphenylamine; Disease Progression; Heparin; Humans; Lymphoma; Multiple Myeloma; Neoplasm Staging; Oligonucleotide Array Sequence Analysis; Prognosis; Protein Binding; Proteoglycans; Thyroid Neoplasms; Transmembrane Activator and CAML Interactor Protein; Tumor Necrosis Factor Ligand Superfamily Member 13	2009
American Society of Hematology--48th Annual Meeting and Exposition. Updates on therapies. 9-12 December 2006 Orlando, FL, USA. IDrugs : the investigational drugs journal, 2007, Volume: 10, Issue:2 Topics: Anemia, Sickle Cell; Antibiotics, Antineoplastic; Antigens, CD20; Benzamides; Benzenesulfonates; CD40 Antigens; Diphenylamine; Hematologic Neoplasms; Hematology; Humans; Ki-1 Antigen; Leukemia, Myeloid; Lymphoma; MAP Kinase Kinase Kinases; Niacinamide; Phenylurea Compounds; Pyridines; Sirolimus; Sorafenib	2007

Article

Year

APRIL is overexpressed in cancer: link with tumor progression.

BMC cancer, 2009, Mar-16, Volume: 9

Topics: B-Cell Activating Factor; B-Cell Activation Factor Receptor; B-Lymphocytes; Biomarkers, Tumor; Carcinoma; Cell Proliferation; Cell Survival; Diphenylamine; Disease Progression; Heparin; Humans; Lymphoma; Multiple Myeloma; Neoplasm Staging; Oligonucleotide Array Sequence Analysis; Prognosis; Protein Binding; Proteoglycans; Thyroid Neoplasms; Transmembrane Activator and CAML Interactor Protein; Tumor Necrosis Factor Ligand Superfamily Member 13

2009

American Society of Hematology--48th Annual Meeting and Exposition. Updates on therapies. 9-12 December 2006 Orlando, FL, USA.

IDrugs : the investigational drugs journal, 2007, Volume: 10, Issue:2

Topics: Anemia, Sickle Cell; Antibiotics, Antineoplastic; Antigens, CD20; Benzamides; Benzenesulfonates; CD40 Antigens; Diphenylamine; Hematologic Neoplasms; Hematology; Humans; Ki-1 Antigen; Leukemia, Myeloid; Lymphoma; MAP Kinase Kinase Kinases; Niacinamide; Phenylurea Compounds; Pyridines; Sirolimus; Sorafenib

2007